SCHEMBL2160308

SCHEMBL2160308

CN(CO)C(=O)c1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.55
LMNA P02545 1/20 0.55
NAPRT Q6XQN6 1/20 0.55
P4HTM Q9NXG6 1/20 0.55
ALDH1A1 P00352 2/20 0.53
CES2 O00748 1/20 0.52
CES1 P23141 1/20 0.52
GAA P10253 1/20 0.50
CTNNB1 P35222 1/20 0.47
WNT3A P56704 1/20 0.47
KDM4E B2RXH2 1/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
HSD17B10 Q99714 3/20 0.47
TP53 P04637 2/20 0.47
KMT2A Q03164 2/20 0.46
GSK3B P49841 1/20 0.44
ALOX15 P16050 1/20 0.44
MEN1 O00255 1/20 0.43
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26676066 0.86 ALDH1A1 (0.50) L3MBTL1LMNANAPRTP4HTMALDH1A1
SCHEMBL1281847 0.86 LMNA (0.52) L3MBTL1LMNANAPRTP4HTMALDH1A1
SCHEMBL16741186 0.86 ALDH1A1 (0.53) L3MBTL1LMNANAPRTP4HTMALDH1A1
Hydrochloric Acid SCHEMBL30476602 0.84 ALDH1A1 (0.52) L3MBTL1LMNANAPRTP4HTMALDH1A1
SCHEMBL30975229 0.83 ALOX15 (0.52) L3MBTL1LMNANAPRTP4HTMALDH1A1
SCHEMBL30975215 0.83 ALDH1A1 (0.50) L3MBTL1LMNANAPRTP4HTMALDH1A1
SCHEMBL31098476 0.81 NPC1 (0.53) L3MBTL1LMNANAPRTP4HTMALDH1A1
SCHEMBL7035328 0.81 ALDH1A1 (0.49) L3MBTL1LMNANAPRTP4HTMALDH1A1
SCHEMBL31098597 0.81 CNR1 (0.56) L3MBTL1LMNANAPRTP4HTMALDH1A1
SCHEMBL29516254 0.81 ALDH1A1 (0.61) L3MBTL1LMNANAPRTP4HTMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11779018-B2 Heterocyclic compound and arthropod pest control composition containing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-10-10 US disclosed
US-8664248-B2 Derivatives of pyridoxine for inhibiting HIV integrase TAIMED BIOLOGICS, INC. (TW) 2014-03-04 US disclosed
US-20120329827-A1 DERIVATIVES OF PYRIDOXINE FOR INHIBITING HIV INTEGRASE AMBRILIA BIOPHARMA, INC. (CA) 2012-12-27 US disclosed
US-8283366-B2 Derivatives of pyridoxine for inhibiting HIV integrase AMBRILIA BIOPHARMA, INC. (CA) 2012-10-09 US disclosed
US-20110184028-A1 DERIVATIVES OF PYRIDOXINE FOR INHIBITING HIV INTEGRASE TAIMED BIOLOGICS, INC. (TW) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110184028-A1 DERIVATIVES OF PYRIDOXINE FOR INHIBITING HIV INTEGRASE PNPO, IMPDH1, DPYD L3MBTL1 3099/4885LMNA 1522/4885NAPRT 20/4885
US-11779018-B2 Heterocyclic compound and arthropod pest control composition containing same C5, PRXL2A, NOX3 L3MBTL1 139/4885LMNA 2635/4885NAPRT 1435/4885
US-20120329827-A1 DERIVATIVES OF PYRIDOXINE FOR INHIBITING HIV INTEGRASE PNPO, IMPDH1, DPYD L3MBTL1 3099/4885LMNA 1522/4885NAPRT 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.